Global mRNA Cancer Vaccines and Therapeutics Market Overview And Scope:
Global mRNA Cancer Vaccines and Therapeutics Market Size was estimated at USD 167.52 million in 2022 and is projected to reach USD 480.3 million by 2028, exhibiting a CAGR of 19.19% during the forecast period.
The Global mRNA Cancer Vaccines and Therapeutics Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of mRNA Cancer Vaccines and Therapeutics utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology
Global mRNA Cancer Vaccines and Therapeutics Market Segmentation
By Type, mRNA Cancer Vaccines and Therapeutics market has been segmented into:Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
By Application, mRNA Cancer Vaccines and Therapeutics market has been segmented into:
Infectious Disease
Cancer
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The mRNA Cancer Vaccines and Therapeutics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the mRNA Cancer Vaccines and Therapeutics market.
Top Key Players Covered in mRNA Cancer Vaccines and Therapeutics market are:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Objective to buy this Report:
1. mRNA Cancer Vaccines and Therapeutics analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with mRNA Cancer Vaccines and Therapeutics market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: mRNA Cancer Vaccines and Therapeutics Market by Type
5.1 mRNA Cancer Vaccines and Therapeutics Market Overview Snapshot and Growth Engine
5.2 mRNA Cancer Vaccines and Therapeutics Market Overview
5.3 Adeno Carcinomas
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Adeno Carcinomas: Geographic Segmentation
5.4 Mucinous Carcinomas
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Mucinous Carcinomas: Geographic Segmentation
5.5 Adenosquamous Carcinomas
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Adenosquamous Carcinomas: Geographic Segmentation
Chapter 6: mRNA Cancer Vaccines and Therapeutics Market by Application
6.1 mRNA Cancer Vaccines and Therapeutics Market Overview Snapshot and Growth Engine
6.2 mRNA Cancer Vaccines and Therapeutics Market Overview
6.3 Infectious Disease
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Infectious Disease: Geographic Segmentation
6.4 Cancer
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Cancer: Geographic Segmentation
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 mRNA Cancer Vaccines and Therapeutics Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 mRNA Cancer Vaccines and Therapeutics Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 mRNA Cancer Vaccines and Therapeutics Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 MODERNA THERAPEUTICS
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CUREVAC
7.4 TRANSLATE BIO
7.5 BIONTECH
7.6 SANGAMO THERAPEUTICS
7.7 ARGOS THERAPEUTICS
7.8 IN-CELL-ART
7.9 ETHERNA
7.10 ETHRIS
7.11 TIBA BIOTECHNOLOGY
Chapter 8: Global mRNA Cancer Vaccines and Therapeutics Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Adeno Carcinomas
8.2.2 Mucinous Carcinomas
8.2.3 Adenosquamous Carcinomas
8.3 Historic and Forecasted Market Size By Application
8.3.1 Infectious Disease
8.3.2 Cancer
8.3.3 Others
Chapter 9: North America mRNA Cancer Vaccines and Therapeutics Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Adeno Carcinomas
9.4.2 Mucinous Carcinomas
9.4.3 Adenosquamous Carcinomas
9.5 Historic and Forecasted Market Size By Application
9.5.1 Infectious Disease
9.5.2 Cancer
9.5.3 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe mRNA Cancer Vaccines and Therapeutics Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Adeno Carcinomas
10.4.2 Mucinous Carcinomas
10.4.3 Adenosquamous Carcinomas
10.5 Historic and Forecasted Market Size By Application
10.5.1 Infectious Disease
10.5.2 Cancer
10.5.3 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe mRNA Cancer Vaccines and Therapeutics Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Adeno Carcinomas
11.4.2 Mucinous Carcinomas
11.4.3 Adenosquamous Carcinomas
11.5 Historic and Forecasted Market Size By Application
11.5.1 Infectious Disease
11.5.2 Cancer
11.5.3 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific mRNA Cancer Vaccines and Therapeutics Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Adeno Carcinomas
12.4.2 Mucinous Carcinomas
12.4.3 Adenosquamous Carcinomas
12.5 Historic and Forecasted Market Size By Application
12.5.1 Infectious Disease
12.5.2 Cancer
12.5.3 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Adeno Carcinomas
13.4.2 Mucinous Carcinomas
13.4.3 Adenosquamous Carcinomas
13.5 Historic and Forecasted Market Size By Application
13.5.1 Infectious Disease
13.5.2 Cancer
13.5.3 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America mRNA Cancer Vaccines and Therapeutics Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Adeno Carcinomas
14.4.2 Mucinous Carcinomas
14.4.3 Adenosquamous Carcinomas
14.5 Historic and Forecasted Market Size By Application
14.5.1 Infectious Disease
14.5.2 Cancer
14.5.3 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
mRNA Cancer Vaccines and Therapeutics Scope:
|
Report Data
|
mRNA Cancer Vaccines and Therapeutics Market
|
|
mRNA Cancer Vaccines and Therapeutics Market Size in 2022
|
USD 167.52 million
|
|
mRNA Cancer Vaccines and Therapeutics CAGR 2023 - 2030
|
19.19%
|
|
mRNA Cancer Vaccines and Therapeutics Base Year
|
2022
|
|
mRNA Cancer Vaccines and Therapeutics Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology.
|
|
Key Segments
|
By Type
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
By Applications
Infectious Disease
Cancer
Others
|
